Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma

Published:2021-12-17 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tian Lu¹²,Zhao Luqing¹²,Sze Karen Man‐Fong¹²,Kam Charles Shing¹²,Ming Vanessa Sheung‐In¹²,Wang Xia¹²,Zhang Vanilla Xin¹²,Ho Daniel Wai‐Hung¹²,Cheung Tan‐To²³,Chan Lo‐Kong¹²,Ng Irene Oi‐Lin¹²^ORCID

Affiliation:

1. Department of Pathology The University of Hong Kong Hong Kong

2. State Key Laboratory of Liver Research The University of Hong Kong Hong Kong

3. Department of Surgery The University of Hong Kong Hong Kong

Funder

Health and Medical Research Fund

Research Grants Council, University Grants Committee

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32236

Reference42 articles.

1. Hyperactive Ras in developmental disorders and cancer

2. The ral gene: a new ras related gene isolated by the use of a synthetic probe.

3. The RalGEF/Ral pathway: Evaluating an intervention opportunity for Ras cancers;Cooper JM;Enzymes,2013

4. Ral GTPases in tumorigenesis: Emerging from the shadows

5. Ral GTPases: crucial mediators of exocytosis and tumourigenesis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma;European Journal of Cancer;2024-10

2. A review of nuclear Dbf2-related kinase 1 (NDR1) protein interaction as promising new target for cancer therapy;International Journal of Biological Macromolecules;2024-02

3. Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells;Cellular and Molecular Gastroenterology and Hepatology;2024

4. Effectively utilizing publicly available databases for cancer target evaluation;NAR Cancer;2023-06-09

5. Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker;Frontiers in Immunology;2022-11-17